FCGRT and acquired epidermolysis bullosa: Taking our results together, we have here demonstrated the efficacy of anti‐FcRn treatment in experimental murine EBA and concluded that the therapeutic effects of anti‐FcRn treatment are associated with a reduced concentration of circulating and tissue‐bound autoantibodies targeting COL7.